Knowledge Center

Presentation / Sep 10, 2015

Screening methodologies to expedite the formulation development of amorphous solid dispersions

Authors:
  • Iris Duarte
  • João Henriques
  • João F. Pinto
  • Marcio Temtem
Source:
2015 APS Presentation, Íris Duarte

Related links

2015 APS Presentation - Screening methodologies

Also in the Knowledge Center

Related Content

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Hovione certified as a Top Employer in all of its manufacturing sites

Press Release / Jan 18, 2024
Article
View

Dispersome®

Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more